CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Biopharma reverse mergers rise 1,600% in Q3 to rival IPOs

Neutral
AI Analysis

Summary

Biotechs are increasingly using reverse mergers to access public markets, with Q3 reverse merger activity rising 1,600% and nearly matching traditional IPO volumes this year.

Importance:2/10
Sentiment:
0.00
reverse_mergerIPOpublic_marketsmarket_trend

Read the original article

Published by BioSpace on September 2, 2026 4:39 AM

Read Original